Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Completed
A Study of Efinopegdutide in Participants With Hepatic Impairment (MK-6024-014)
NCT06052566· Phase 1· Merck Sharp & Dohme LLC· Source
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error